FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3137223497> ?p ?o ?g. }

• W3137223497 abstract "Background and importance Intravenous immunoglobulin (IVIg) is a blood derived medicinal product prescribed for a range of medical conditions. Clinical evidence strongly supports the use of IVIg as firstline therapy in three neurological disorders; chronic inflammatory demyelinating polyneuropathy (CIDP), Guillain–Barre syndrome (GBS) and multifocal motor neuropathy. There are an increasing number of other neurological conditions where IVIg is used despite limited evidence based data. Careful consideration of the efficacy of IVIg in each indication is required as it is a limited resource associated with high costs and potential supply shortages. Aim and objectives To review the clinical indications for IVIg use in neurology patients at the Mater Misericordiae University Hospital (MMUH) and to compare prescribing practices to international evidence based guidelines. Material and methods All neurology patients treated with IVIg between 2016 and 2018 were retrospectively reviewed using patient medical notes and pharmacy functionalities at the MMUH. Data collected included indication, dose prescribed, total number of IVIg courses, use of alternative therapies before IVIg and documentation of clinical benefit. Results were compared with international evidence based guidelines and verified by a neurology consultant. Results 67 patients were included in the study. IVIg was prescribed for 15 indications. The most common were GBS, myasthenia gravis and CIDP. 31 patients received IVIg for licensed indications, whereas 36 patients received IVIg for unlicensed indications. The level of evidence from international evidence based guidelines supported the use of IVIg for most indications. Conclusion and relevance This study demonstrated that IVIg was prescribed for a variety of neurological conditions at the MMUH, the majority of which were unlicensed. IVIg use was supported for most indications compared with international evidence based guidelines. However, IVIg was prescribed for several indications despite limited evidence of efficacy. This study highlights the need for evidence based clinical practice guidelines for IVIg use at the MMUH and Ireland. References and/or acknowledgements Perez EE, et al. Update on the use of immunoglobulin in human disease: A review of evidence. J Allergy Clin Immunol 2017. Updated Commissioning Criteria for the use of therapeutic immunoglobulin in immunology, haematology, neurology and infectious diseases in England January 2019. Department of Health 2019. National Blood Authority of Australia. Criteria for the clinical use of intravenous immunoglobulins in Australia. October 2019. Conflict of interest No conflict of interest" @default.
• W3137223497 created "2021-03-29" @default.
• W3137223497 creator A5026477393 @default.
• W3137223497 creator A5031244084 @default.
• W3137223497 creator A5042828194 @default.
• W3137223497 creator A5058642891 @default.
• W3137223497 creator A5089980624 @default.
• W3137223497 date "2021-03-01" @default.
• W3137223497 modified "2023-10-17" @default.
• W3137223497 title "4CPS-262 Clinical efficacy of intravenous immunoglobulin in neurology: a retrospective cohort study at the Mater Misericordiae University Hospital" @default.
• W3137223497 doi "https://doi.org/10.1136/ejhpharm-2021-eahpconf.94" @default.
• W3137223497 hasPublicationYear "2021" @default.
• W3137223497 type Work @default.
• W3137223497 sameAs 3137223497 @default.
• W3137223497 citedByCount "0" @default.
• W3137223497 crossrefType "proceedings-article" @default.
• W3137223497 hasAuthorship W3137223497A5026477393 @default.
• W3137223497 hasAuthorship W3137223497A5031244084 @default.
• W3137223497 hasAuthorship W3137223497A5042828194 @default.
• W3137223497 hasAuthorship W3137223497A5058642891 @default.
• W3137223497 hasAuthorship W3137223497A5089980624 @default.
• W3137223497 hasBestOaLocation W31372234971 @default.
• W3137223497 hasConcept C104863432 @default.
• W3137223497 hasConcept C118552586 @default.
• W3137223497 hasConcept C126322002 @default.
• W3137223497 hasConcept C159654299 @default.
• W3137223497 hasConcept C16568411 @default.
• W3137223497 hasConcept C167135981 @default.
• W3137223497 hasConcept C177713679 @default.
• W3137223497 hasConcept C187212893 @default.
• W3137223497 hasConcept C188313352 @default.
• W3137223497 hasConcept C194828623 @default.
• W3137223497 hasConcept C203014093 @default.
• W3137223497 hasConcept C21715850 @default.
• W3137223497 hasConcept C2778105408 @default.
• W3137223497 hasConcept C2778691916 @default.
• W3137223497 hasConcept C2779867792 @default.
• W3137223497 hasConcept C2780052305 @default.
• W3137223497 hasConcept C512399662 @default.
• W3137223497 hasConcept C522805319 @default.
• W3137223497 hasConcept C71924100 @default.
• W3137223497 hasConcept C72563966 @default.
• W3137223497 hasConceptScore W3137223497C104863432 @default.
• W3137223497 hasConceptScore W3137223497C118552586 @default.
• W3137223497 hasConceptScore W3137223497C126322002 @default.
• W3137223497 hasConceptScore W3137223497C159654299 @default.
• W3137223497 hasConceptScore W3137223497C16568411 @default.
• W3137223497 hasConceptScore W3137223497C167135981 @default.
• W3137223497 hasConceptScore W3137223497C177713679 @default.
• W3137223497 hasConceptScore W3137223497C187212893 @default.
• W3137223497 hasConceptScore W3137223497C188313352 @default.
• W3137223497 hasConceptScore W3137223497C194828623 @default.
• W3137223497 hasConceptScore W3137223497C203014093 @default.
• W3137223497 hasConceptScore W3137223497C21715850 @default.
• W3137223497 hasConceptScore W3137223497C2778105408 @default.
• W3137223497 hasConceptScore W3137223497C2778691916 @default.
• W3137223497 hasConceptScore W3137223497C2779867792 @default.
• W3137223497 hasConceptScore W3137223497C2780052305 @default.
• W3137223497 hasConceptScore W3137223497C512399662 @default.
• W3137223497 hasConceptScore W3137223497C522805319 @default.
• W3137223497 hasConceptScore W3137223497C71924100 @default.
• W3137223497 hasConceptScore W3137223497C72563966 @default.
• W3137223497 hasLocation W31372234971 @default.
• W3137223497 hasOpenAccess W3137223497 @default.
• W3137223497 hasPrimaryLocation W31372234971 @default.
• W3137223497 hasRelatedWork W12466429 @default.
• W3137223497 hasRelatedWork W15277033 @default.
• W3137223497 hasRelatedWork W17239941 @default.
• W3137223497 hasRelatedWork W18503960 @default.
• W3137223497 hasRelatedWork W18623487 @default.
• W3137223497 hasRelatedWork W20357161 @default.
• W3137223497 hasRelatedWork W3635225 @default.
• W3137223497 hasRelatedWork W7453485 @default.
• W3137223497 hasRelatedWork W7953823 @default.
• W3137223497 hasRelatedWork W8568685 @default.
• W3137223497 isParatext "false" @default.
• W3137223497 isRetracted "false" @default.
• W3137223497 magId "3137223497" @default.
• W3137223497 workType "article" @default.